Latest News

• share
• favorite_border

Immunotherapy trial in metastatic triple negative breast cancer patients proves to shrink tumors in patients.

• share
• favorite_border

A study from NYU Langone Medical Center researchers published in JAMA Internal Medicine finds that initiating statins in heart-healthy older adults may not extend lifespan.

• share
• favorite_border

Incidental discovery of a kidney tumor in a chest scan leads to robotic surgery for kidney cancer.

• share
• favorite_border

The U.S. Food and Drug Administration has granted accelerated approval to a second drug in less than a month for first-line treatment for advanced bladder cancer – again based on clinical trial findings from the same researcher from NYU Langone’s Perlmutter Cancer Center.

• share
• favorite_border

Use of the erectile dysfunction drug Viagra does not cause the development of melanoma, a deadly form of skin cancer.

• share
• favorite_border

Maintaining the supply of a molecule that helps to nourish cartilage prevented osteoarthritis in animal models of the disease, according to a report published in Nature Communications online May 11.

• share
• favorite_border

Robert J. Cerfolio, MD – whose innovations in robotics have led to practice-changing advances in lung cancer surgery – will join NYU Langone as chief of clinical thoracic surgery. He also will become the first director of the Lung Cancer Center at NYU Langone’s Perlmutter Cancer Center.

• share
• favorite_border

Pablo G. Castañeda, MD, an internationally renowned expert in pediatric and adolescent hip conditions, has joined Hassenfeld Children’s Hospital of New York at NYU Langone as its new chief of pediatric orthopedic surgery. Prior to joining, he practiced for 10 years in Mexico City.

• share
• favorite_border

Findings from a clinical trial led by a researcher at NYU Langone’s Perlmutter Cancer Center helped pave the way for the recent, accelerated approval by the U.S. Food and Drug Administration (FDA) of a highly effective immunotherapy as first line treatment for patients with advanced bladder cancer who are not eligible for treatment with standard chemotherapy

• share
• favorite_border

More Americans than ever before suffer from serious psychological distress, and the country’s ability to meet the growing demand for mental health services is rapidly eroding.

• share
• favorite_border

Loud workplace noise has been found by many studies to cause harm, but a recent analysis links the sounds of all-night car horn blasts and shouting by bar revelers in New York City’s noisiest neighborhoods to unexplained improvements in body weight and blood pressure for the urban poor living there.

• share
• favorite_border

NYU Lutheran is expanding maternity services to serve a growing Brooklyn. Ming C. Tsai, MD, will lead the way as the newly appointed chief of OB/GYN.

• share
• favorite_border

Medical oncologist Ophira Ginsburg, MD, has joined NYU Langone’s Perlmutter Cancer Center as director of its new High Risk Program, which identifies, studies and cares for patients with hereditary syndromes that increase cancer risk.

• share
• favorite_border

Hematologist-oncologist Ahmad Samer Al-Homsi MD, MBA, will lead a new bone marrow transplantation program at NYU Langone’s Perlmutter Cancer Center for treating blood-borne cancers, including leukemia, lymphoma and multiple myeloma, and utilize transplantation as an adjunct to immunotherapy for solid tumors.

• share
• favorite_border

NYU Langone study finds “yo-yo” dieting can increase the odds of stroke, heart attack, and death in people with coronary artery disease.

• share
• favorite_border

Genetic testing of tumor and blood fluid samples from people with and without one of the most aggressive forms of skin cancer has shown that two new blood tests can reliably detect previously unidentifiable forms of the disease.

• share
• favorite_border

Renowned neurologist and critical care specialist Jennifer A. Frontera, MD, joins NYU Lutheran as chief of neurology, with an eye to expand neurocritical care.

• share
• favorite_border

Seeking to further enhance mental health services for veterans and their families, the Steven A. Cohen Military Family Clinic (MFC) at NYU Langone and VA New York Harbor Healthcare System (VANYHHS) signed a Memorandum of Understanding formalizing the existing partnership between the two organizations.

• share
• favorite_border

Marc Bjurlin, DO, (right) director of urologic oncology at NYU Lutheran Medical Center, used state-of-the-art technology to help patient Mikhail Kurbesov beat prostate cancer.

• share
• favorite_border

Specialized nerve cells, known as somatostatin-expressing (Sst) interneurons, in the outer part of the mammalian brain (or cerebral cortex) — play a key role in controlling how information flows in the brain when it is awake and alert. This is the finding of a study published online in Science March 2 by a team of neuroscientists at NYU Langone Medical Center and its Neuroscience Institute.

• share
• favorite_border

Current treatments for rheumatoid arthritis relieve the inflammation that leads to joint destruction, but the immunologic defect that triggers the inflammation persists to cause relapses. Now the results of a new study suggest that clinical trials for new rheumatoid arthritis (RA) drugs should shift from their sole focus on relieving inflammation to eliminating the B cells that produce these antibodies.

• share
• favorite_border

A specific gene that helps form memories from traumatic events can be manipulated – and in doing so may actually help prevent post-traumatic stress disorder (PTSD), according to a new study led NYU Langone Medical Center.

• share
• favorite_border

In a concerted effort to help address the unique and complex needs of patients with headaches and migraines, NYU Langone has recruited nationally renowned expert Lawrence Newman, MD, to serve as its new director of the division of Headache Medicine division and as professor (clinical) in the Department of Neurology, where he will lead research and clinical efforts to combat these conditions that can drastically affect a patient’s quality of life.

• share
• favorite_border

Theodore H. Welling, III, MD, will lead a new state-of-the-art liver cancer program at NYU Langone to advance clinical care and accelerate the translation of lab breakthroughs into superior treatments.

• share
• favorite_border

The diversity of Brooklyn’s population has transformed the practice of infectious diseases that is akin to global medicine at NYU Lutheran Medical Center.

• share
• favorite_border

The pediatric neuropsychology program at NYU Lutheran, led by Gianna Locascio, PsyD, brings a new level of care to Brooklyn families.

• share
• favorite_border

Scientists at NYU Langone Medical Center have discovered the mechanisms behind a genetic change known to cause a set of related diseases.

• share
• favorite_border

Responding to demands from cities across the country, NYU School of Medicine’s Department of Population Health, NYU’s Robert F. Wagner School of Public Service, and the National Resource Network, with support from the Robert Wood Johnson Foundation, are launching the City Health Dashboard. The online data visualization tool will greatly improve city-level understanding of health and empower mayors, city managers, health officials, and other local stakeholders to enact policies that target the risk factors and health conditions that most impact their communities.

• share
• favorite_border

Perlmutter Cancer Center at NYU Langone Medical Center is again joining with each of the 69 National Cancer Institute (NCI)-designated cancer centers in issuing a joint statement to increase vaccination against the human papillomavirus (HPV).

• share
• favorite_border

Millions of Americans suffer each year from ailments of the ears, nose and throat (ENT)—with a significant number occurring in children and adolescents. NYU Lutheran Medical Center is addressing these problems head on for families in Brooklyn through an expanded ENT program under the auspices of the nationally ranked Otolaryngology (ENT) Department at NYU Langone Medical Center.

• share
• favorite_border

NYU Langone Medical Center has announced that internationally recognized surgeon and scientist Diane M. Simeone, MD, will join its Perlmutter Cancer Center on March 1 to serve as associate director for translational research and to lead its newly established pancreatic cancer center.

• share
• favorite_border

Dan Iofifescu, MD, MSc, a clinician-scientist specializing in mood disorders, has been recruited to the Psychiatry faculty at NYU Langone Medical Center, furthering the department’s national reputation in diagnosing and managing depression and related disorders.

• share
• favorite_border

Elizabeth Hammer, MD, has been appointed director of the Sunset Park, Brooklyn, medical center's dialysis unit. Dr. Hammer, a highly trained nephrologist, will lead the unit's expansion and emphasize patient safety and quality.

• share
• favorite_border

Naomi Michele Simon, MD, MSc, a world renowned expert in complicated grief and anxiety disorders, is joining the faculty of NYU Langone's Department of Psychiatry to spearhead a new initiative into these illnesses.

• share
• favorite_border

The combination of two new drugs that harness the body’s immune system is safe and effective, destroying most cancer cells in 64 percent of patients with recurrent Hodgkin lymphoma, according to the results of an early-phase study.

• share
• favorite_border

When combined with psychological counseling, a single dose of a mind-altering compound contained in psychedelic mushrooms significantly lessens mental anguish in distressed cancer patients for months at a time, according to results of a clinical trial led by researchers at NYU Langone Medical Center.

• share
• favorite_border

NYU Langone receives $15 million for a five-year research grant from the National Eye Institute to evaluate treatment for shingles of the eye.

• share
• favorite_border

Jeffrey S. Weber, MD, PhD, deputy director of NYU Langone’s Perlmutter Cancer Center, has received a 2016 “Giants of Cancer Care” Award, presented by OncLive, a professional organization for oncologists.

• share
• favorite_border

At NYU Lutheran Medical Center and hospitals nationwide, a new team of doctors called “hospitalists” have become a regular presence, specially trained to deliver comprehensive care to inpatients.

• share
• favorite_border

The newly implemented emergency department care model at NYU Lutheran Medical Center has introduced a new model of care to improve efficiency and provide a better patient experience.

• share
• favorite_border

The brain’s interpretation of sound is influenced by cues from other senses, explaining more precisely how we interpret what we hear at a particular moment, according to a report published in Nature Neuroscience online Oct. 31.

• share
• favorite_border

Experiments designed to reveal how a protein protects the lungs from asthma-related damage suggest a new way to treat a rare disease marked by the inability of cells to break down fats, according to a report in EBioMedicine published online Oct. 25.

• share
• favorite_border

Endometrial cancer expert Ghadir Salame, MD, from NYU Lutheran Medical Center in Brooklyn is helping women in the borough -- and beyond -- address this life-threatening issue through advanced treatment, including robotic-assisted surgery.

• share
• favorite_border

A new report on Swedish men with non-aggressive prostate cancer suggests that a lot more American men could safely choose to monitor their disease instead of seeking immediate radiation treatment or surgery.

• share
• favorite_border

Annual health care costs and lost earnings in the United States from low-level but daily exposure to hazardous chemicals commonly found in plastic bottles, metal food cans, detergents, flame retardants, toys, cosmetics, and pesticides, exceeds $340 billion, according to a detailed economic analysis by researchers at NYU Langone Medical Center.

• share
• favorite_border

Throughout her distinguished career, cancer researcher Dafna Bar-Sagi, PhD, has made fundamental contributions to the understanding of the mechanisms that drive the disease. In recognition of her accomplishments, she has been named a recipient of the Outstanding Investigator Award, a highly prestigious honor presented by the National Cancer Institute (NCI).

• share
• favorite_border

As section chief for gastroenterology and hepatology at NYU Lutheran Medical Center, Dr. George Abdelsayed will connect with the many cultural enclaves throughout Brooklyn to develop a hepatitis C screening program to help promote early detection of the disease.

• share
• favorite_border

Dr. Feza Remzi named Director of IBD Center at NYU Langone Medical Center.

• share
• favorite_border

A new survey of children’s and teenagers’ eating habits at fast-food restaurants suggests that consumption levels of sugary drinks are closely tied to their automatic inclusion in “combo meal” packages.

• share
• favorite_border

After her own experience surviving breast cancer, philanthropist Beatrice Welters wanted to “pay it forward” -- and help educate other women about breast cancer and the importance of early detection. And she is doing just that -- through a new program at NYU Langone -- the Beatrice W. Welters Breast Health Outreach and Navigation Program.